Salient Pharma ApS: Financial statements 2021
CVR: 36900709
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Salient Pharma ApS (CVR 36900709) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -259,487 and a net result of DKK -301,256 compared with DKK -901,594 the year before. Equity in the 2021 report amounted to DKK -793,203.
- Gross Profit
- DKK -259,487
- Profit/Loss
- DKK -301,256
- Equity
- DKK -793,203
- Total Assets
- DKK 54,900
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -259 t. | -301 t. | -793 t. | 0 |
| 2020 | - | -485 t. | -902 t. | -492 t. | 1 |
| 2019 | - | -730 t. | -2.4 mio. | 410 t. | 1 |
| 2018 | - | -838 t. | -710 t. | 2.8 mio. | - |
| 2017 | - | -1.2 mio. | -971 t. | -1.8 mio. | - |
Official annual report
Find more companies like Salient Pharma ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Salient Pharma ApS has published its annual report for 2020. Gross profit came to DKK -484,922, and the net result was DKK -901,594.
About Salient Pharma ApS
Salient Pharma ApS is a Danish company of the type Anpartsselskab based in Glostrup, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Salient Pharma IVS and ZeroTaste IVS. The management consists of Ulrik Spork. The board consists of Helle Bøwadt, Søren Wang Petersen and Ulrik Spork. The company is owned by HB-MEDICAL HOLDING ApS, CAND.PHARM. POVL M. ASSENS FOND and SPORCON LIFESCIENCE ADVISORS ApS. The company has 1 employee (2020). In 2025, the company reported a gross profit of DKK -129,889 and a net result of DKK -218,345 compared with DKK -202,180 the year before. Equity in the 2025 report amounted to DKK -1,344,010.